4//SEC Filing
Randhawa Simrat 4
Accession 0001992260-25-000005
CIK 0001690585other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 8:01 PM ET
Size
5.5 KB
Accession
0001992260-25-000005
Insider Transaction Report
Form 4
Randhawa Simrat
EVP, Head of R&D
Transactions
- Award
Stock Option (Right to Buy)
2025-09-23+60,000→ 60,000 totalExercise: $37.87Exp: 2035-09-23→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after September 23, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Documents
Issuer
Dianthus Therapeutics, Inc. /DE/
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001992260
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 8:01 PM ET
- Size
- 5.5 KB